BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 36451988)

  • 1. Retrospective analysis of the role of retrobulbar amphotericin-B injection in the management of COVID-19 associated rhino-orbito-cerebral-mucormycosis.
    Yadav R; Madan S; Rohatgi J; Ansari A; Sharma R; Gautam P; Rai P; Das GK; Sahu PK; Arora V
    Pan Afr Med J; 2022; 42():312. PubMed ID: 36451988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of transcutaneous retrobulbar Amphotericin B (TRAMB) as an adjuvant therapy for rhino-orbital-cerebral mucormycosis (ROCM) following COVID-19.
    Shakrawal J; Sharma V; Goyal A; Kumar D; Meena S; Tiwari S; Jain V; Elhence P; Soni K; Choudhury B; Bhatnagar K; Garg MK; Misra S
    Int Ophthalmol; 2023 Jun; 43(6):1919-1926. PubMed ID: 36427099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of Transcutaneous Retrobulbar Amphotericin B in Rhino-Orbital-Cerebral Mucormycosis Among Patients Recovering From COVID-19: A Preliminary Experience.
    Sinha S; Kumar VB; Kumar A; Singh V; Anand A; Kusumesh R; Mishra S; Raj P; Sinha BP
    Cureus; 2022 Aug; 14(8):e27817. PubMed ID: 36106303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcutaneous retrobulbar amphotericin B for rhino-orbital-cerebral mucormycosis: a multi-center retrospective comparative study.
    Dallalzadeh LO; Ediriwickrema LS; Fung SE; Men CJ; Kossler AL; Kupcha AC; Mawn LA; Burkat CN; van Landingham SW; Conger JR; Simmons B; Pham C; Akella SS; Setabutr P; Ho T; Couch SM; Kim JS; Demirci H; Korn BS; Kikkawa DO; Liu CY
    Orbit; 2024 Feb; 43(1):41-48. PubMed ID: 36880205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcutaneous retrobulbar injection of amphotericin B in rhino-orbital-cerebral mucormycosis: a review.
    Nair AG; Dave TV
    Orbit; 2022 Jun; 41(3):275-286. PubMed ID: 34720026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of transcutaneous retrobulbar injection of liposomal amphotericin B in post-COVID-19 rhino-orbito-cerebral mucormycosis: Our experience.
    Ramamurthy LB; Bhandari R; Kanakpur S; Thejaswini P
    Indian J Ophthalmol; 2022 Mar; 70(3):1019-1024. PubMed ID: 35225564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcutaneous retrobulbar amphotericin-B (TRAMB) injection in orbital mucormycosis.
    Singh P; Gupta A; Sanepalli SR; Raj A
    BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35361668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of transcutaneous retrobulbar amphotericin B in COVID-19-associated mucormycosis.
    Rizvi SWA; Khan S; Shahbaz M; Gounder MS; Saif M; Khalid S
    Indian J Ophthalmol; 2023 Feb; 71(2):452-456. PubMed ID: 36727338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrobulbar Injection of Amphotericin B in Patients With COVID-19 Associated Orbital Mucormycosis: A Systematic Review.
    Sharifi A; Akbari Z; Shafie'ei M; Nasiri N; Sharifi M; Shafiei M; Zand A
    Ophthalmic Plast Reconstr Surg; 2022 Sep-Oct 01; 38(5):425-432. PubMed ID: 35943425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrobulbar Amphotericin B Injection in Curbing the Progression of COVID Associated Rhino-orbital Cerebral Mucormycosis: A Retrospective Case Series.
    Pathak M; Sahu V; Arora RD; Shambharkar MM; Naveen P; Pati SK; Nagarkar NM
    Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):3352-3358. PubMed ID: 36246726
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of COVID-19-associated rhino-orbital-cerebral mucormycosis patients in a tertiary care center in Northern India.
    Yadav H; Sen S; Nath T; Mazumdar S; Jain A; Verma P; Gupta P
    Indian J Ophthalmol; 2022 Jun; 70(6):2163-2168. PubMed ID: 35648004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable.
    Keshri A; Mathialagan A; Aishwarya A; Ravisankar ; Bhuskute G; Kanaujia V; Singh AK; Singh RK; Dhiman RK; Agarwal R
    Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):819-827. PubMed ID: 36053359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis.
    Bhattacharyya A; Sarma P; Kaur H; Kumar S; Bhattacharyya J; Prajapat M; Prakash A; Sharma S; Reddy DH; Thota P; Bansal S; Gautam BS; Medhi B
    Indian J Pharmacol; 2021; 53(6):499-510. PubMed ID: 34975140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients.
    Nair AG; Adulkar NG; D'Cunha L; Rao PR; Bradoo RA; Bapaye MM; Kothari A; Dave TV; Shinde CA
    Orbit; 2021 Dec; 40(6):499-504. PubMed ID: 34338124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhino-orbital-cerebral mucormycosis (ROCM) and associated cerebritis treated with adjuvant retrobulbar amphotericin B.
    Safi M; Ang MJ; Patel P; Silkiss RZ
    Am J Ophthalmol Case Rep; 2020 Sep; 19():100771. PubMed ID: 32551404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical profile, prognostic factors, and outcomes of rhino-orbital-cerebral mucormycosis in the setting of COVID-19: A retrospective study.
    Hanumappa SM; Karuppannasamy D
    Saudi J Ophthalmol; 2023; 37(2):100-106. PubMed ID: 37492213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orbital Mucormycosis: Understanding the Deadly Fungus Sweeping the Globe.
    Farooq S; Khan NA; Singh A; Khan A; Sharma P; Meena R; Jakhar A; Kumar M; Kochar A
    Cureus; 2023 Jun; 15(6):e41010. PubMed ID: 37519583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Presentations, Management and Outcomes of Rhino-Orbital-Cerebral Mucormycosis (ROCM) Following COVID-19: A Multi-Centric Study.
    Dave TV; Gopinathan Nair A; Hegde R; Vithalani N; Desai S; Adulkar N; Kamal S; Mittal R; Bradoo RA
    Ophthalmic Plast Reconstr Surg; 2021 Sep-Oct 01; 37(5):488-495. PubMed ID: 34314399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrobulbar injection of amphotericin B using intravenous cannula for post-COVID-19 rhino-orbital mucormycosis.
    Murthy R; Bagchi A; Gote Y; Desai S
    Indian J Ophthalmol; 2022 Jan; 70(1):302-305. PubMed ID: 34937263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrobulbar Injection of Amphotericin B for Orbital Mucormycosis.
    Hirabayashi KE; Kalin-Hajdu E; Brodie FL; Kersten RC; Russell MS; Vagefi MR
    Ophthalmic Plast Reconstr Surg; 2017; 33(4):e94-e97. PubMed ID: 27768642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.